STAT+: Launch prices for new medicines dipped slightly last year but remain high, analysis finds
The median net price for 202 newly launched medicines rose by 35%, to $257,000 last year from $173,000 in 2022.
New medicines launched in 2025 experienced a 35% increase in their net price, adjusted for inflation, reaching an average of $257,000 per drug, according to an analysis by the Institute for Clinical and Economic Review and West Health. This figure represents a slight dip in launch prices for new medicines compared to the previous year. Nearly a quarter of the drugs launched that year exceeded $500,000 in annual net price, while 34% were priced between $200,000 and $500,000.
Interestingly, the median list price for these drugs rose by 24% during the same period, reaching $293,000 when adjusted for inflation. List prices are typically higher than net prices due to the inclusion of manufacturer discounts. The analysis does not delve into the reasons behind the discrepancy between list and net prices, but it suggests that these differences may vary depending on the type of drug.
Written by urgent.news from STAT News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
